| Literature DB >> 26301121 |
Abstract
Given the increasing commercial and clinical relevance of probiotics, improving their stress tolerance profile and ability to overcome the physiochemical defences of the host is an important biological goal. Herein, I review the current state of the art in the design of engineered probiotic cultures, with a specific focus on their utility as therapeutics for the developing world; from the treatment of chronic and acute enteric infections, and their associated diarrhoeal complexes, to targeting HIV and application as novel mucosal vaccine delivery vehicles.Entities:
Keywords: BetL; Bifidobacterium; Gastrointestinal tract; Lactobacillus; Listeria monocytogenes; Probiotics
Year: 2015 PMID: 26301121 PMCID: PMC4540709 DOI: 10.4291/wjgp.v6.i3.73
Source DB: PubMed Journal: World J Gastrointest Pathophysiol ISSN: 2150-5330